BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/6/2020 9:25:46 AM | Browse: 635 | Download: 907
 |
Received |
|
2019-11-19 11:44 |
|
Peer-Review Started |
|
2019-11-19 11:45 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2019-12-04 02:32 |
|
Revised |
|
2019-12-12 23:51 |
|
Second Decision |
|
2020-01-06 10:34 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2020-01-08 17:13 |
|
Articles in Press |
|
2020-01-08 17:13 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2020-02-28 02:02 |
|
Typeset the Manuscript |
|
2020-03-04 06:38 |
|
Publish the Manuscript Online |
|
2020-03-06 09:25 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Medicine, Research & Experimental |
| Manuscript Type |
Case Control Study |
| Article Title |
Significance of 125I radioactive seed implantation on growth differentiation factor and programmed death receptor-1 during treatment of oral cancer
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Gang Xue, Yao Feng and Jia-Bin Li |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Jia-Bin Li, MSc, Attending Doctor, Department II of Oral and Maxillofacial Surgery, The Second Affiliated Hospital of Jiamusi University, No.522, Hongqi Street, Jiamusi 154000, Heilongjiang, China. jiping199210@126.com |
| Key Words |
125I radioactive seed; Oral cancer; Growth differentiation factor 11; Programmed death receptor-1; Prognosis; Recurrence |
| Core Tip |
125I radioactive seed implantation for oral cancer (OC) can effectively improve the clinical efficacy of patients and reduce their recurrence rate, thus having great clinical application prospect. By detecting growth differentiation factor 11 and programmed death receptor-1 of patients during the treatment, we discover that they have a good predictive value for the efficacy and recurrence of OC patients, and both may be potential targets for future OC treatment. |
| Publish Date |
2020-03-06 09:25 |
| Citation |
Xue G, Feng Y, Li JB. Significance of 125I radioactive seed implantation on growth differentiation factor and programmed death receptor-1 during treatment of oral cancer. World J Clin Cases 2020; 8(5): 874-886 |
| URL |
https://www.wjgnet.com/2307-8960/full/v8/i5/874.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v8.i5.874 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
